The small GTP-binding proteins of the Rho family, consisting of the Rho, Rac, and Cdc42 subfamilies, are implicated in various cell functions, such as cell shape change, cell motility and cytokinesis, through reorganization of actin cytoskeleton. Rho GDI is a general regulator which forms a complex with the GDP-bound inactive form of the Rho family members and inhibits their activation. We have puri®ed Rho GDI from the yeast Saccharomyces cerevisiae, cloned its gene, and named it RDI1 (Rho GD). In this study, we have further characterized yeast Rho GDI. Rho GDI was found in the cytosol by immunoblot and immuno¯uorescence microscopic analyses. Rho1p and Cdc42p were co-immunoprecipitated with Rho GDI from the cytosol. This immunoprecipitated Rho1p was mainly bound to GDP. In the disruption mutant of Rho GDI, which did not show any apparent phenotype, both Rho1p and Cdc42p were also present in the cytosol. These results indicate that yeast Rho GDI possesses properties similar to those of mammalian Rho GDI, and that there is a cytosolic factor which functionally substitutes for Rho GDI in yeast.
Introduction
The Rho family belongs to the small G protein superfamily consisting of the Rho, Rac, and Cdc42 subfamilies (Hall, 1994; . Evidence is accumulating that the Rho family members regulate various cell functions, such as cell shape change, cell motility, and cytokinesis, through the reorganization of actin cytoskeleton. Recently, various proteins have been identi®ed as potential targets of the Rho family members (Tapon and Hall, 1997) and these targets may play important roles in the action of the Rho family members.
The Rho family members have two interconvertible forms: GDP-bound inactive and GTP-bound active forms (Hall, 1994; . The GDP bound form is converted to the GTP-bound form by the GDP/GTP exchange reaction which is stimulated by GDP/GTP exchange proteins (GEPs) and is inhibited by GDP dissociation inhibitors (GDIs). After the GTPbound form transduces a signal to a downstream target, the GTP-bound form is converted to the GDPbound form by the GTPase reaction which is regulated by GTPase activating proteins (GAPs). Three GDIs, including Rho GDI (Fukumoto et al., 1990; , Ly/D4 GDI (Lelias et al., 1993; Scherle et al., 1993) , and Rho GDI-3 (Zalcman et al., 1996) , have so far been reported to be active on the Rho family members. Of these GDIs, Rho GDI has been most intensively studied . The Rho family members are found in both the cytosol and membrane fractions. The Rho family members in the cytosol fraction are complexed with Rho GDI, indicating that the Rho family members in this fraction are in the inactive state. Therefore, it is presumable that the Rho family members complexed with Rho GDI in the cytosol are released from the inhibitory action of Rho GDI and are activated by their GEPs. However, the GEPs for the Rho family members themselves have been shown not to be enough to activate the Rho family members complexed with Rho GDI Yaku et al., 1994) .
The budding yeast Saccharomyces cerevisiae possesses the Rho family members, including RHO1, RHO2 (Madaule et al., 1987) , RHO3, RHO4 (Matsui and Toh-e, 1992) and CDC42 (Adams et al., 1990; Johnson and Pringle, 1990) . It oers an attractive system to solve the problems described above, since a powerful molecular genetical approach is applicable. Cells of this yeast grow by budding for cell division, and the actin cytoskeleton plays a pivotal role in the budding process (Drubin, 1991) . RHO1 is a homolog of the mammalian RhoA gene and has been shown to be an essential gene in S. cerevisiae (Madaule et al., 1987) . We have recently shown that cells of the rho1 mutants stop growing with small-budded cells under restrictive conditions . Moreover, immuno¯uorescence microscopic study indicates that Rho1p is localized at the growth site where cortical actin patches are localized . These results suggest that RHO1 is involved in the process of bud formation and that Rho1p also regulates reorganization of actin cytoskeleton like in mammalian cells. In fact, we have recently shown that BNI1 regulates the reorganization of actin cytoskeleton as a target of RHO1 Imamura et al., 1997) . Concerning the upstream regulators of RHO1, we have puri®ed a homolog of Rho GDI in yeast, cloned its gene, and named it RDI1 (Masuda et al., 1994) . The amino acid sequence of yeast Rho GDI is 36% identical to mammalian Rho GDI and it is active on the lipid-modi®ed, but not lipid-unmodi®ed, Rho family members like mammalian Rho GDI. We have also cloned two homologous genes, ROM1 and ROM2, and have shown that at least Rom2p is a Rho1p-speci®c GEP, and that Rom2p is not enough to activate Rho1p complexed with Rho GDI either .
In this work, we have further characterized yeast Rho GDI. The results indicate that yeast Rho GDI possesses properties similar to those of mammalian Rho GDI. Moreover, our results suggest that, in the disruption mutant of Rho GDI, an unknown factor forms a complex with each member of the Rho family members.
Results

Cytosolic localization of Rho GDI
We ®rst examined whether Rho GDI is present in the cytosol or on the membrane in S. cerevisiae. Strain OHNY3 was transformed with a single copy plasmid pRS316-RDI1 or pRS316-HA-RDI1. A protein with an apparent molecular mass of 30 kDa was detected by immunoblot analysis with the anti-HA antibody in the cytosol fraction, but not in the membrane fraction, of OHNY3 expressing HA-Rho GDI (Figure 1 ). Since this band was not detected in OHNY3 expressing nontagged Rho GDI, we concluded that the 30 kDa protein is HA-Rho GDI and that HA-Rho GDI is present exclusively in the cytosol in S. cerevisiae.
Localization of Rho GDI was also examined cytologically in OHNY3 expressing HA-Rho GDI by use of the indirect immuno¯uorescence microscopic method. The cytoplasm, but not the nucleus or any other intracellular structure, was stained with the anti-HA antibody in unbudded, small budded, and large budded cells (Figure 2 ). This cytoplasmic staining of HA-Rho GDI was not seen in OHNY3 expressing non-tagged Rho GDI (data not shown). These results also indicate that Rho GDI is present in the cytosol.
Co-immunoprecipitation of Rho GDI with Rho1p or Cdc42p
In order to study the association between Rho GDI and Rho1p or Cdc42p, OHNY3 cells were cotransformed with pRS316-myc-RDI1 and pRS315-HA-RHO1 or pRS315-HA-CDC42. Expression of each protein was con®rmed by immunoblotting of the cell lysates with the anti-myc or -HA antibody (data not shown). HA-Rho1p and HA-Cdc42p were coimmunoprecipitated with myc-Rho GDI (Figure 3) . Therefore, we concluded that Rho GDI is complexed with Rho1p and Cdc42p in the cytosol. HA-Rho1p was immunoprecipitated with the anti-HA antibody from the lysates and the bound guanine nucleotides were analysed (Figure 4 ). HA-Rho1p was exclusively bound to GDP, indicating that Rho1p complexed with Rho GDI is in the GDP-bound form.
Cytosolic localizations of Rho1p and Cdc42p in the disruption mutant of Rho GDI
We have shown that the disruption mutant of Rho GDI does not show any apparent phenotype (Masuda et al., 1994) . Eect of the disruption of Rho GDI on the membrane-cytosol distribution of Rho1p and Cdc42p was examined. The wild-type and the Rho GDI disruption mutant strains were transformed with pRS316-HA-RHO1 or pRS316-HA-CDC42. Proteins of the membrane and supernatant fractions of each transformant were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) and blotted onto a nitrocellulose membrane ®lter, and HA-Rho1p and HA-Cdc42p were detected with the anti-HA antibody ( Figure 5 ). The relative amounts of HA-Rho1p and HA-Cdc42p in the cytosol and membrane fractions were not dierent between the wild-type and Rho GDI disruption mutant strains. It has been shown that Rho GDI inhibits the ADPribosylation of Rho by C. botulinum exoenzyme C3 . Therefore, it could be examined whether endogenous Rho1p is complexed with Rho GDI or a Rho GDI-like protein by using exoenzyme C3. We studied eect of the disruption of Rho GDI on the accessibility of exoenzyme C3 to endogenous Rho1p. The reaction was performed with the cytosol and membrane fractions of the wild-type and Rho GDI disruption strains. There was no dierence in the distribution and amount of [ 32 P]ADP-ribosylated Rho1p between the wild-type and Rho GDI disruption mutant strains ( Figure 6 ). The [ 32 P]ADP-ribosylation of the cytosolic Rho1p was only observed after removal of inhibitory low molecular mass compounds, possibly NAD, through dialysis. Interestingly, incorporation of [ 32 P]ADP-ribose into Rho1p is stronger in the membrane fraction than in the cytosol fraction in both the wild-type and Rho GDI disruption mutant strains. These results indicate that disruption of Rho GDI does not show any eect on the membranecytosol distributions of Rho1p and Cdc42p, and that Rho1p in the cytosol fraction of the Rho GDI disruption mutant is complexed with a Rho GDI-like protein.
Eect of Rho GDI overexpression on the cytosolic concentrations of Rho1p and Cdc42p
We have shown that overexpression of yeast or mammalian Rho GDI inhibits the growth of yeast cells (Masuda et al., 1994) . It was examined whether this overexpression of Rho GDI shows any eect on the cytosolic concentration of Rho1p or Cdc42p. Yeast strains expressing HA-Rho1p or HA-Cdc42p under control of their native promoters were transformed HA-Rho1p HA-Cdc42p
-HA-Cdc42p HA-Rho1p - Figure 5 Cytosolic localizations of Rho1p and Cdc42p in the disruption mutant of Rho GDI. Cells of OHNY1 wild-type strain or the Rho GDI disruption mutant expressing HA-Rho1p or HACdc42p were lysed, and the lysates were separated into the cytosol and membrane fractions. The same amount (30 mg) of total proteins of each fraction was separated by SDS ± PAGE, and HARho1p and HA-Cdc42p were detected by immunoblot analysis with the anti-HA antibody. Lanes 1, 3, 5 and 7, the cytosolic fraction; lanes 2, 4, 6 and 8, the membrane fraction. WT, the wild type strain; rdi1, the Rho GDI disruption mutant Figure 6 ADP-ribosylation by exoenzyme C3 of Rho1p in the disruption mutant of Rho GDI. Cells of OHNY1 and the Rho GDI disruption mutant expressing HA-Rho1p were lysed, and the lysates were separated into the cytosol and membrane fractions. A part of the cytosol fraction was dialyzed to obtain the dialyzed cytosol fraction. Each fraction was incubated with C. botulinum exoenzyme C3 and [
P]NAD to [
32 P]ADP-ribosylate Rho1p. Proteins were separated by SDS ± PAGE followed by autoradiography. The band with a molecular mass higher than Rho1p in lane 6 is most likely HA-Rho1p expressed in the disruption mutant of Rho GDI. Lanes 1 ± 3, the wild-type strain; lanes 4 ± 6, the disruption mutant of Rho GDI; lanes 1 and 4, the nondialyzed cytosol fractions; lanes 2 and 5, the dialyzed cytosol fractions; lanes 3 and 6, the membrane fractions. The molecular mass standards (in kDa) are shown at the left with pKT10-GAL1-RDI1, which overexpresses yeast Rho GDI. Overexpression of Rho GDI was induced by shifting yeast cells from a glucose-to galactosecontaining medium. A signi®cant increase of HARho1p or HA-Cdc42p was observed in the cytosol fraction, but not in the membrane fraction, of the Rho GDI-overexpressing strain (Figure 7) . Therefore, yeast cells overexpress Rho1p and Cdc42p to compensate for the growth-inhibitory eect caused by the overexpression of Rho GDI.
Discussion
In this study, we have demonstrated that yeast Rho GDI is exclusively present in the cytosol. Rho GDI has also been found in the cytosol of cells from rat kidney, liver, brain, heart, spleen, and testis (Shimizu et al., 1991; Boivin and Beliveau, 1995) , and of human and bovine neutrophils (Bourmeyster et al., 1992; Bokoch et al., 1994) . Moreover, we have shown that Rho GDI is complexed with the GDP-bound forms of Rho1p and Cdc42p in the cytosol. We have ®rst shown that Rho GDI forms a complex preferentially with the GDP-bound form of RhoB in vitro . Later, the complex formation between Rho GDI and RhoA and Cdc42 has been demonstrated in the cytosol of insulin secreting rat RINNm5F cells (Regazzi et al., 1992) , bovine neutrophils (Bourmeyster et al., 1992) , rabbit brain (Backlund, 1993) , and rat kidney cortex (Boivin and Beliveau, 1995) . Taken together, the functions and modes of action of Rho GDI seem to be conserved between yeast and mammalian cells.
We have shown that Rho GDI prevents the binding of RhoB to synaptic plasma membranes and erythrocyte ghosts and is even able to extract RhoB from these membranes (Isomura et al., 1991) . These results suggest that the function of Rho GDI is to keep the GDP-bound forms of the Rho family members in the cytosol. However, we have shown that Rho1p and Cdc42p are present in the cytosol even in the disruption mutant of Rho GDI. This result is consistent with our result that the disruption mutant of Rho GDI does not show any phenotype (Masuda et al., 1994) . Overexpression of yeast or mammalian Rho GDI results in the inhibition of yeast cell growth (Masuda et al., 1994) Mack et al., 1996) . Since Rom7p/Bem4p directly interacts with the Rho family members, Rom7p/Bem4p may be the protein which forms a complex with Rho1p and Cdc42p in the disruption mutant of Rho GDI. However, the biochemical properties of Rom7p/Bem4p are dierent from those of Rho GDI: Rom7p/Bem4p interacts with both the GDP-and GTP-bound forms of Rho1p and does not exhibit either of a GEP, GDI, or GAP activity toward Rho1p. Moreover, the rom7/bem4 rdi1 double mutant is not lethal, although its growth was somewhat slower than the rom7/bem4 single mutant (data not shown). Therefore, Rom7p/Bem4p does not seem to be a functional homolog of Rho GDI. Very recently, we have identi®ed a candidate for the functional homolog of Rho GDI (K Shimizu, K Tanaka, T Ohtsuka, G Koch and Y Takai, unpublished data). Puri®cation of this protein will be important to reveal the regulation of the Rho family members.
It is currently unknown whether a functional homolog of Rho GDI is also conserved in mammalian cells. Since Rho GDI is conserved between yeast and mammalian cells, a functional homolog of Rho GDI may also be conserved in mammalian cells. We have recently reported that the Rho subfamily members regulate the Ezrin/Radixin/Moesin (ERM)-CD44 system (Takaishi et al., 1995; Hirao et al., 1996) , which has been implicated in reorganization of actin ®laments in mammalian cells (Arpin et al., 1994) . More recently, we have demonstrated that the ERM family members directly interact with Rho GDI to initiate the activation of the Rho family members by reducing the Rho GDI activity (K Takahashi, T Sasaki, A Mammoto, K Takaishi, T Kameyama, S Tsukita, S Tsukita and Y Takai, submitted). It is possible that a functional homolog of Rho CDI is involved in the ERM-mediated activation of the Rho family members. It is also possible that an ERM-like protein is involved in the activation of the Rho family members in yeast, although a structural homolog of the ERM family members is not encoded in the yeast genome (data not shown). Identi®cation and puri®cation of functional homologs of Rho GDI in yeast and mammalian cells are necessary to clarify the modes of activation of the Rho family members.
Materials and methods
Strains, media and yeast transformations
Yeast strains used were wild-type strains OHNY1 (MATa ura3 leu2 his3 trpl ade2) and OHNY3 (MATa/MATa ura3/ ura3 leu2/leu2 his3/his3 trpl/trpl ade2/ade2), and the Rho GDI disruption mutant OHNY-TM1 (MATa ura3 leu2 his3 ade2 rdi1 :: HIS3) (Masuda et al., 1994) . Yeast strains were grown in YPDAU rich media that contained 2% Bactopeptone (Difco Laboratories, Detroit, MI), 1% Bacto-yeast extract (Difco), 0.04% adenine sulfate, 0.02% uracil and 2% glucose. Yeast transformations were performed by the lithium acetate methods (Gietz et al., 1992 Figure 7 Eect of Rho GDI overexpression on the cytosolic concentration of Rho1p and Cdc42p. Cells of OHNY1 expressing HA-Rho1p or HA-Cdc42p were transformed with pKT10-GAL1-RDI1, which overexpresses Rho GDI in the SGal medium. Cells of each transformant were grown in either SD or SGal medium for 10 h, and the lysates were fractionated into the cytosol and membrane fractions. HA-Rho1p and HA-Cdc42p were detected by immunoblot analysis with the anti-HA antibody. Lanes 1, 3, 5 and 7, SGal medium; lanes 2, 4, 6 and 8, SD medium. The molecular mass standards (in kDa) are shown at the left were grown in SD medium that contained 2% glucose and 0.7% yeast nitrogen base without amino acids (Difco). To induce the expression of the Rho GDI gene, cells were grown in the SGal medium that contained 2% galactose and 0.7% yeast nitrogen base without amino acids (Difco). Amino acids and bases were supplemented to SD and SGal medium when required. Standard yeast genetic manipulations were performed as described (Sherman et al., 1986 ). An E. coli strain DH5a was used for construction and propagation of plasmids.
Molecular biological techniques
Standard molecular biological techniques were used for construction of plasmids, DNA sequencing, and PCR (Sambrook et al., 1989) . DNA sequences were determined using ALFred DNA sequencer (Pharmacia Biotech, Inc., Uppsala, Sweden) and PCRs were performed using GeneAmp PCR System 2400 (Perkin-Elmer, Norwalk, CT). Restriction enzyme sites were introduced by the PCR mutagenesis methods (Higuchi, 1989) .
Plasmids
Plasmids used in this study are listed in Table 1 . Plasmids containing HA-CDC42, HA-RDI1 and myc-RDI1 were constructed as described for the construction of HA-RHO1 . In these plasmids, oligonucleotides encoding HA or myc epitope were inserted at the site immediately before an initiator codon of each open reading frame.
Materials and chemicals
The BA-85 (0.45 mm pore size) nitrocellulose membrane ®lter was purchased from Schleicher & Schuell (Dassel, Germany). C. botulinum exoenzyme C3 was kindly provided by K Aktories (University of Freiburg). The 12CA5 (Wilson et al., 1984; Field et al., 1988) and 9E10 (Evan et al., 1985) mouse monoclonal antibodies were used as the anti HA and -myc antibodies, respectively. The BSA-saturated charcoal was prepared as follows. Twenty ml (bed volume) of Norit A (Sigma) was mixed with 20 ml of 20 mg/ml bovine serum albumin (BSA) in H 2 O and the mixture was shaken for 12 h. After centrifugation for 10 min at 2000 g, the BSA solution was removed and the charcoal was washed twice with the homogenization buer.
Immunoblot analysis
About 1610 8 cells, grown in the appropriate medium, were harvested by centrifugation for 5 min at 2000 g and washed once in H 2 O and once in a homogenization buer (50 mM Tris-HCl [pH 7.5], 1 mM EDTA, 1 mM dithiothreitol [DTT] , 100 mM NaCl, 5 mM MgCl 2 , 10 mM p-amidinophenyl methanesulfonyl¯uoride-HCl [APMSF], 1 mg/ml leupeptin, 2 mM benzamidine and 5 mg/ml aprotinin). Yeast cells were resuspended in 0.5 ml of the homogenization buer and lysed with 0.4 ml of glass beads (0.45 mm in diameter) by vortexing for 15 min at 48C. Cell debris was subsequently removed by centrifugation for 5 min at 450 g. The cytosol and membrane fractions were obtained by centrifugation for 1 h at 100 000 g. The pellet (the membrane fraction) was twice rinsed with the homogenization buer and resuspended by brief sonication in the same volume of the homogenization buer as the supernatant (the cytosol fraction). Proteins (60 mg of each sample) were separated by SDS ± PAGE, blotted onto a nitro-cellulose membrane ®lter, and probed with the anti-HA or -myc antibody. Protein-antibody complexes were detected with the sheep anti-mouse IgG conjugated to alkaline phosphatase (Amersham Corp., Arlington Heights, IL) and ECL Western blotting detection system (Amersham Corp.).
Immunoprecipitation of HA-Rholp or HA-Cdc42p
Strain OHNY1 containing pRS316-myc-RDI1 and pRS315-HA-RHO1 or pRS316-myc-RDI1 and pRS315-HA-CDC42 was grown in SD medium. Cells were lysed and the 100 000 g supernatant fraction was obtained as described above. The supernatant fraction was incubated for 1 h at 48C with the anti-HA antibody (5 mg) coupled to 2 mg of Protein A Sepharose CL-4B (Pharmacia LKB Biotechnology Inc.). The Protein A Sepharose beads were washed three times with the homogenization buer. Proteins bound were eluted by boiling and subjected to SDS ± PAGE. Immunoblot analysis was performed using the anti-myc antibody.
Analysis of guanine nucleotides bound to HA-Rholp
Identi®cation of guanine nucleotides bound to Rholp was performed as described (Gibbs et al., 1987) with several modi®cations. About 1610 8 cells of OHNY1 containing pRS316-RHO1 or pRS316-HA-RHO1 were inoculated into 3 ml of the low phosphate minimal medium (Rubin, 1975) . After 20 min of preincubation, 0.5 mCi of carrier-free [ 32 P]orthophosphate (Amersham) was added and the culture was further incubated for 3 h at 308C. Cells were subsequently collected, washed, and lysed in the 0.5 ml of a buer containing 50 mM Tris-HC1 (pH 7.5), 1 mM DTT, 300 mM NaCl, 20 mM MgCl 2 , 10 mM APMSF, 1 mg/ml leupeptin, 2 mM benzamidine, 5 mg/ml aprotinin, 1 mM sodium orthovanadate, 0.1 mM NaF, and 0.5% Nonidet P40 as described above. Free nucleotides were removed from the lysate by addition of 0.3 ml (bed volume) of the BSAsaturated charcoal. HA-Rho1p was immunoprecipitated with the anti-HA antibody as described above. Nucleotides bound to HA-Rho1p were eluted with an elution buer (20 mM Tris-HCl [pH 7.5], 20 mM EDTA, 2 mM GDP, 2 mM GTP and 400 mM sodium formate) and spotted onto a (PEI)-cellulose plate (Polygram CEL 300 PEI, Macherey-NAGEL, Germany) which was subsequently developed with 1 M KH 2 PO 4 (pH 4.0) and analysed using the Fujix BAS 2000 phosphor imager (Fuji Photo Film; Japan).
ADP-ribosylation reaction
ADP-ribosylation reaction was performed essentially as described (Aktories et al., 1988) . OHNYl and OHNY-TM1 containing pRS316-HA-RHO1 were grown in YPDAU medium and SD medium with casamino acids, respectively. Yeast cells were lysed and the cytosol and membrane pRS315-HA-RHO1 pRS316-HA-CDC42 pRS315-HA-CDC42 pRS316-RDI1 pRS316-HA-RDI1 pRS316-myc-RDI1 pKT10-GAL1-RDI1 URA3, CEN6; (Sikorski and Hieter, 1989 ) LEU2, CEN6; (Sikorski and Hieter, 1989 ) URA3, CEN6, HA-RHO1; ) LEU2, CEN6, HA-RHO1 URA3, CEN6, HA-CDC42 LEU2, CEN6, HA-CDC42 URA3, CEN6, RDI1 URA3, CEN6, HA-RDI1 URA3, CEN6, myc-RDI1 URA3, GAL1-RDI1: (Masuda et al., 1994) fractions were prepared as described above. A half of the cytosol fraction was dialyzed for 12 h at 48C in the homogenization buer to remove the endogenous inhibitors of ADP-ribosylation. About 100 mg of total proteins were incubated for 30 min at 308C with 0.5 mg/ml C. botulinum exoenzyme C3 in the reaction mixture (50 ml) containing 10 mM triethanolalmine-HCl (pH 7.5), 1 mM EDTA, 1 mM DTT, 1.6 mM MgCl 2 , 1 mM APMSF, 300 mM GDP, and 0.1 mM [ 32 P]NAD. The reaction was terminated by the addition of Laemmli's buer (Laemmli, 1970) . Proteins were separated by SDS ± PAGE and radioactive bands were visualized with the phosphor imager (Molecular Dynamics Inc., USA).
Miscellaneous techniques
Indirect immuno¯uorescence microscopic studies of Rho GDI were performed as described .
Protein concentrations were determined by the dye-binding method with bovine serum albumin as a standard (Bradford, 1976) .
